Overnight Switch Trial From Pramipexole IR to Pramipexole ER in Patients With Early Parkinson Disease
NCT00558025
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
156
Enrollment
INDUSTRY
Sponsor class
Conditions
Parkinson Disease
Interventions
DRUG:
Pramipexole Extended Release
DRUG:
Pramipexole Immediate Release
Sponsor
Boehringer Ingelheim